ANTISCAR: Advanced Healing Solution for Chronic Wounds
ANTISCAR is a revolutionary filmogenic liquid bandage designed for the treatment of chronic wounds such as venous ulcers, pressure ulcers, and diabetic ulcers. Its unique formulation and advanced technology accelerate the healing process, reduce the risk of infection, and improve the quality of life for patients. The product is easy to apply, comfortable, and does not limit patient mobility. Clinical trials have shown significant improvements in healing time, infection rates, and overall patient quality of life.
ANTISCAR: Revolutionizing Wound Care with Innovative Liquid Bandage
Introduction to ANTISCAR
ANTISCAR is a revolutionary product for wound care, presented in the form of an innovative liquid bandage. It is specifically designed to treat chronic wounds, bedsores, and ulcers in an effective and rapid manner. Its cutting-edge technology and unique formulation accelerate the healing process and minimize complications often associated with these types of skin lesions.
The Protective Barrier and Hydrating Agents
ANTISCAR employs specific polymers capable of forming a protective barrier on the wound. This barrier prevents bacteria from entering the wound, thereby minimizing the risk of infection. Additionally, ANTISCAR contains hydrating agents that maintain a moist environment conducive to cellular and tissue regeneration, a crucial step for effective healing.
Clinical Study and Results
A clinical study published in the journal Diabetes Research and Clinical Practice revealed that ANTISCAR significantly improves healing in patients with chronic wounds and diabetic foot ulcers. The results showed not only a reduction in healing time but also a decrease in the risk of infection.
Ease of Use and Comfort
Our product is not only effective but also easy to use. It does not require any specific equipment for its application. Moreover, the product is discreet and flexible, making it comfortable for the patient and does not limit their mobility.
Innovative Technology: Matrix Metalloproteinases (MMPs) Inhibition
ANTISCAR utilizes an innovative technology of Matrix Metalloproteinases (MMPs) inhibition. MMPs are enzymes that degrade the components of the extracellular matrix, a structure that supports and surrounds cells in tissues. An excess of MMP activity can hinder healing. ANTISCAR’s technology regulates MMP activity, thereby promoting tissue regeneration and faster healing.
ANTISCAR: A Comprehensive Solution
ANTISCAR offers a comprehensive solution for the treatment of chronic wounds, bedsores, and ulcers. This product accelerates the healing process, protects against infections, is easy to apply, provides comfort to the patient, and utilizes innovative MMP inhibition technology for optimal healing.
Clinical Trial Results: Proving ANTISCAR’s Effectiveness
Clinical trial results demonstrate ANTISCAR’s effectiveness in treating chronic wounds and diabetic foot ulcers. The liquid bandage ANTISCAR accelerates the healing process, reduces the risk of infection, and improves the quality of life of patients. The healing time was reduced significantly in the treatment group compared to the control group. On average, wounds healed 2.1 times faster with the use of ANTISCAR. The healing rate, measured by the reduction in wound surface area, was significantly higher in patients treated with ANTISCAR. After 4 weeks of treatment, 56.3% of wounds in the treatment group had healed, compared to only 31.5% in the control group. The risk of infection was reduced by 50% with the use of ANTISCAR, which can be attributed to the protective film formed by the liquid bandage, preventing the entry of bacteria. Patients treated with ANTISCAR reported an improvement in their quality of life in terms of pain, mobility, and comfort compared to the control group.
Understanding Different Types of Ulcers: Venous, Pressure, and Diabetic Ulcers
Venous Ulcers: A Result of Impaired Blood Flow
Venous ulcers, also known as stasis ulcers, are open sores that occur when the leg veins don’t return blood back toward the heart as they should. This is often due to damaged valves in the veins that allow blood to flow backward and pool in the leg veins, leading to increased pressure and resulting in an ulcer.
Pressure Ulcers: The Consequence of Prolonged Pressure
Pressure ulcers, also known as bedsores, are injuries to the skin and underlying tissue resulting from prolonged pressure on the skin. They most often develop on skin that covers bony areas of the body, such as the heels, ankles, hips, and tailbone. People most at risk of pressure ulcers are those with a medical condition that limits their ability to change positions or those who spend most of their time in a bed or chair.
Diabetic Ulcers: A Complication of Diabetes
Diabetic ulcers are sores that occur on the feet of people with type 1 and type 2 diabetes. Diabetic foot ulcers occur because of nerve damage and peripheral vascular disease associated with diabetes. Nerve damage, also known as neuropathy, leads to loss of sensation in the feet, which can prevent a person from noticing an injury or pressure sore on the foot. Peripheral vascular disease reduces blood flow to the feet, making it hard for a wound or infection to heal.
The Importance of Prompt and Effective Treatment
These types of ulcers can lead to serious complications if not treated promptly and effectively. They can become infected, leading to further health problems, and in severe cases, may require amputation. Therefore, effective treatment and management of these ulcers are crucial.
CLAIMS IN LINE WITH THE NEW REGULATION
- Osmotic cleaning action
- Prevents wound aggravation
- Cleanses the wound
- Accelerates healing
- Protects wounds from impurities
- Maintains wound hydration
Title : Clinical evidence to demonstrate that simultaneous growth of epithelial and fibroblast cells is essential for deep wound healing.
Journal : Clinical Research and Clinical Trials | 2011
TYPE OF TRIAL: Randomized, double-blind clinical trial against placebo | 6 weeks
PATIENTS: N=93 | Test product = 52 ; Comparator = 41
INCLUSION: Patients with at least one lower-extremity chronic wound lasting longer than 2-months
Link to the publication
Reduced healing time:
Patients in the treatment group experienced a significant reduction in healing time compared to the control group. On average, wounds healed 2.1 times faster with the use of ANTISCAR.
Improved healing rate:
The healing rate, measured by the reduction in wound surface area, was significantly higher in patients treated with ANTISCAR. After 4 weeks of treatment, 56.3% of wounds in the treatment group had healed, compared to only 31.5% in the control group.
Decreased risk of infection:
Patients in the treatment group had a significantly lower infection rate than those in the control group. The use of ANTISCAR reduced the risk of infection by 50%, which can be attributed to the protective film formed by the liquid dressing, preventing the entry of bacteria.
Improved quality of life:
Patients treated with ANTISCAR reported an improvement in their quality of life in terms of pain, mobility, and comfort compared to the control group.
These clinical results demonstrate the effectiveness of ANTISCAR in the treatment of chronic wounds and diabetic foot ulcers. The ANTISCAR liquid dressing helps to accelerate the healing process, reduce the risk of infection, and improve the quality of life of patients.
|Indication||Filmogenic liquid bandage for the cicatrization of venous ulcers, pressure ulcers (bedsores) and ulcers of diabetic patients.|
|Composition||Filmogenic glycerol, xanthan gum, honey, MMP-cyanidin, association of Camellia sinensis and Vaccinium myrtillus.|
|Class||MDD Class IIa | MDR Class IIa|
|Direction||Apply in wounds, 2-3 times a day.|
|Precautions||The product is intended for topical use only (damage skin surface) and should not be swallowed. Keep out of reach and sight of children.|
|Storage conditions||Below 25°C|
|Legal manufacturer||VITROBIO (France)|